The All India Institute of Medical Sciences (AIIMS) in Delhi, in collaboration with Nurithm Lab, has released DermaAid, a smartphone app that uses artificial intelligence (AI) to diagnose skin diseases.
The primary goal of this artificial intelligence-enabled application is to address access and accuracy issues in the clinical diagnosis of dermatological illnesses, such as skin and oral cancers.
Dr. Somesh Gupta, a Professor in the Department of Dermatology and Venereology at AIIMS, revealed this development to PTI.
According to him, DermaAId is a mobile app that utilizes a machine learning AI-driven algorithm to make a simple smartphone with a 1 MP camera into a skincare tool. Moreover, the newly launched AI app will perform as a clinical decision support tool for general practitioners to enhance their capacity and awareness of skin problems.
Dr. Gupta said, “The technology behind the app is deceptively simple. A doctor takes a photo of lesions on a patient’s body and uploads them to the cloud server. Within 15-30 seconds, the app provides possible disease conditions based on machine analysis of images.”
He further added that the actual diagnosis happens in the backend as the dermatologist-level categorization of skin problems and treatment choices are provided by the AI machine learning algorithms located on the secure server. Acne, psoriasis, eczema, vitiligo, tinea, male alopecia, basal cell carcinoma, squamous cell carcinoma, and melanoma are among skin diseases that the app can detect.
Interestingly, the application has a commendable accuracy of nearly 80%, mentioned officials. The application has the potential to revolutionize the country’s healthcare system as there will be more healthcare data available and faster development of smart analytics. Dr. Gupta claims that India has 12.5 lakh, allopathic practitioners, with only 3.71 lakh having specialized or post-graduate credentials, according to estimates from the Union Health Ministry.
“The app can be handy, especially in rural India where general practitioners are not readily available, and healthcare workers can address the immediate needs. It can also be deployed to screen oral cancer,” he added.